Related Experiment Video
Updated: Aug 14, 2026
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Comparison between in vitro potency tests for Cuban hepatitis B vaccine: contribution to the standardization process
Mario Landys Chovel Cuervo1, Ania Fernández de Castro Yanes
1Centro para el Control Estatal de la Calidad de los Medicamentos (CECMED), Calle 200, No 1706 entre 17 y 19, CP 11600, Siboney, Playa, Ciudad de la Habana, Cuba. lc@ipk.sld.cu
Abstract:
Quality control of recombinant Hepatitis B vaccines performed by National Control Laboratories prior to marketing vaccine batches requires in vivo and or a well validated in vitro potency assays as recommended by WHO technical series. The in vitro test must also demonstrate its suitability for monitoring the consistency of the vaccine manufacturer. The aim of this study was to establish the relationship between both in vitro potency tests performed by Cuban manufacturer and National Control Laboratory for Hepatitis B vaccine and the suitability of our method for monitoring the manufacturer's test results and consistency. We also intended to contribute to the standardisation process consisting of in vitro methods for this vaccine.
